Endovascular thrombectomy with or without intravenous alteplase in acute stroke

Autor: Pengfei, Yang, Yongwei, Zhang, Lei, Zhang, Yongxin, Zhang, Kilian M, Treurniet, Wenhuo, Chen, Ya, Peng, Hongxing, Han, Jiyue, Wang, Shouchun, Wang, Congguo, Yin, Sheng, Liu, Peng, Wang, Qi, Fang, Hongchao, Shi, Jianhong, Yang, Changming, Wen, Conghui, Li, Changchun, Jiang, Jun, Sun, Xincan, Yue, Min, Lou, Meng, Zhang, Hansheng, Shu, Dianjing, Sun, Hui, Liang, Tong, Li, Fuqiang, Guo, Kaifu, Ke, Haicheng, Yuan, Guoping, Wang, Weimin, Yang, Huaizhang, Shi, Tianxiao, Li, Zifu, Li, Pengfei, Xing, Ping, Zhang, Yu, Zhou, Hao, Wang, Yi, Xu, Qinghai, Huang, Tao, Wu, Rui, Zhao, Qiang, Li, Yibin, Fang, Laixing, Wang, Jianping, Lu, Yansheng, Li, Jianhui, Fu, Xihua, Zhong, Yongjun, Wang, Longde, Wang, Mayank, Goyal, Diederik W J, Dippel, Bo, Hong, Benqiang, Deng, Yvo B W E M, Roos, Charles B L M, Majoie, Jianmin, Liu, Shuailing, Yin
Přispěvatelé: ACS - Atherosclerosis & ischemic syndromes, ACS - Microcirculation, Graduate School, Neurology, ANS - Neurovascular Disorders, Radiology and Nuclear Medicine
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: New England journal of medicine, 382(21), 1981-1993. Massachussetts Medical Society
New England Journal of Medicine, 382(21), 1981-1993. Massachussetts Medical Society
ISSN: 0028-4793
Popis: BACKGROUND In acute ischemic stroke, there is uncertainty regarding the benefit and risk of administering intravenous alteplase before endovascular thrombectomy. METHODS We conducted a trial at 41 academic tertiary care centers in China to evaluate endovascular thrombectomy with or without intravenous alteplase in patients with acute ischemic stroke. Patients with acute ischemic stroke from large-vessel occlusion in the anterior circulation were randomly assigned in a 1:1 ratio to undergo endovascular thrombectomy alone (thrombectomy-alone group) or endovascular thrombectomy preceded by intravenous alteplase, at a dose of 0.9 mg per kilogram of body weight, administered within 4.5 hours after symptom onset (combination-therapy group). The primary analysis for noninferiority assessed the between-group difference in the distribution of the modified Rankin scale scores (range, 0 [no symptoms] to 6 [death]) at 90 days on the basis of a lower boundary of the 95% confidence interval of the adjusted common odds ratio equal to or larger than 0.8. We assessed various secondary outcomes, including death and reperfusion of the ischemic area. RESULTS Of 1586 patients screened, 656 were enrolled, with 327 patients assigned to the thrombectomy-alone group and 329 assigned to the combination-therapy group. Endovascular thrombectomy alone was noninferior to combined intravenous alteplase and endovascular thrombectomy with regard to the primary outcome (adjusted common odds ratio, 1.07; 95% confidence interval, 0.81 to 1.40; P=0.04 for noninferiority) but was associated with lower percentages of patients with successful reperfusion before thrombectomy (2.4% vs. 7.0%) and overall successful reperfusion (79.4% vs. 84.5%). Mortality at 90 days was 17.7% in the thrombectomy-alone group and 18.8% in the combination-therapy group. CONCLUSIONS In Chinese patients with acute ischemic stroke from large-vessel occlusion, endovascular thrombectomy alone was noninferior with regard to functional outcome, within a 20% margin of confidence, to endovascular thrombectomy preceded by intravenous alteplase administered within 4.5 hours after symptom onset. (Funded by the Stroke Prevention Project of the National Health Commission of the People’s Republic of China and the Wu Jieping Medical Foundation; DIRECT-MT Clinical-Trials.gov number, NCT03469206.)
Databáze: OpenAIRE
Externí odkaz: